October 17, 2022: After the highly attended panel discussion Data on the Economics of Investing in Early-Stage Life Science Opportunities at the 2023 BIO International Convention in Boston, Merlin Greuel presented an extended version of the dataset at the 2023 annual summit of the Mid Atlantic Bio Angels (MABA) in New York City. After a successful series of presentations, Bioscience Valuation has reaffirmed its leadership in the assessment of early-stage investment opportunities.